1. Home
  2. CRNX vs COLD Comparison

CRNX vs COLD Comparison

Compare CRNX & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.97

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$14.93

Market Cap

4.3B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
COLD
Founded
2008
1903
Country
United States
United States
Employees
N/A
12690
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.3B
IPO Year
2018
2009

Fundamental Metrics

Financial Performance
Metric
CRNX
COLD
Price
$33.97
$14.93
Analyst Decision
Strong Buy
Hold
Analyst Count
8
16
Target Price
$76.75
$14.97
AVG Volume (30 Days)
1.2M
4.7M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
7.67%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,039,000.00
$2,601,846,000.00
Revenue This Year
$720.10
N/A
Revenue Next Year
$184.67
$2.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$10.10
52 Week High
$57.99
$18.08

Technical Indicators

Market Signals
Indicator
CRNX
COLD
Relative Strength Index (RSI) 40.12 57.09
Support Level $33.36 $11.93
Resistance Level $37.23 $15.38
Average True Range (ATR) 1.36 0.45
MACD -0.23 -0.09
Stochastic Oscillator 29.09 49.77

Price Performance

Historical Comparison
CRNX
COLD

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

Share on Social Networks: